Medicare Enrolled
Dr. Liviu Rappaport, M.D.
Pulmonary Disease · Wayne, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rappaport from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rappaport?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rappaport
Dr. Liviu Rappaport is a pulmonary disease specialist in Wayne, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rappaport performed 6,970 Medicare services across 3,437 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rappaport received a total of $3,066 from 43 pharmaceutical and/or device companies across 220 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rappaport is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in NJ
$3,066 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,970
Medicare services
Top 2% in NJ for pulmonary disease
3,437
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~348 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
2,090 | $67 | $155 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
906 | $98 | $289 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
682 | $115 | $281 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
541 | $8 | $15 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
533 | $108 | $294 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
507 | $69 | $158 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
447 | $102 | $223 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
224 | $32 | $96 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
219 | $0 | $20 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
140 | $97 | $231 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
123 | $145 | $431 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
84 | $34 | $68 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
74 | $72 | $130 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
65 | $138 | $376 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
64 | $35 | $93 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
52 | $46 | $121 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $70 | $206 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
28 | $3 | $7 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
28 | $10 | $33 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
27 | $174 | $469 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
19 | $142 | $296 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
18 | $28 | $59 |
| Same-day hospital admission and discharge, moderate complexity This code covers initial hospital care for a patient admitted and discharged on the same day. It applies when the visit involves moderate medical decision making and lasts at least 70 minutes. |
13 | $136 | $359 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
12 | $70 | $218 |
| Annual depression screening | 12 | $21 | $43 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
11 | $22 | $59 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
11 | $94 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,066
Total received (2018-2024)
Avg $438/year across 7 years
Top 42% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
220
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,918 (95.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$148 (4.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$429
2023
$293
2022
$423
2021
$56
2020
$286
2019
$836
2018
$742
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$92
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$46
Mylan Specialty L.P.
$42
Actelion Pharmaceuticals US, Inc.
$36
Amgen Inc.
$31
GlaxoSmithKline, LLC.
$30
PFIZER INC.
$30
Inspire Medical Systems, Inc.
$21
Exact Sciences Corporation
$20
Mallinckrodt Hospital Products Inc.
$19
Otsuka America Pharmaceutical, Inc.
$18
Novo Nordisk Inc
$17
Bayer Healthcare Pharmaceuticals Inc.
$14
Neurelis, Inc.
$13
Top 3 companies account for 42.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$646
GlaxoSmithKline, LLC.
$390
Novo Nordisk Inc
$271
Mallinckrodt Hospital Products Inc.
$208
Sunovion Pharmaceuticals Inc.
$165
Mylan Specialty L.P.
$152
PFIZER INC.
$137
Merck Sharp & Dohme Corporation
$109
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$102
Allergan, Inc.
$62
Janssen Pharmaceuticals, Inc
$62
Kowa Pharmaceuticals America, Inc.
$58
Amgen Inc.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Allergan Inc.
$36
Actelion Pharmaceuticals US, Inc.
$36
Otsuka America Pharmaceutical, Inc.
$34
Dexcom, Inc.
$31
Teva Pharmaceuticals USA, Inc.
$29
Mallinckrodt Enterprises LLC
$28
Radius Health, Inc.
$27
Lilly USA, LLC
$27
Harmony Biosciences LLC
$26
E.R. Squibb & Sons, L.L.C.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$25
Circassia Pharmaceuticals Inc
$25
GENZYME CORPORATION
$22
Inspire Medical Systems, Inc.
$21
Exact Sciences Corporation
$20
Medtronic, Inc.
$17
JAZZ PHARMACEUTICALS INC.
$15
VIVUS, Inc.
$15
Amarin Pharma Inc.
$15
Horizon Therapeutics plc
$15
UCB, Inc.
$15
Merck Sharp & Dohme LLC
$15
Bayer Healthcare Pharmaceuticals Inc.
$14
Lundbeck LLC
$14
Supernus Pharmaceuticals, Inc.
$14
Jazz Pharmaceuticals Inc.
$14
OptiNose US, Inc.
$13
Neurelis, Inc.
$13
Electromed, Inc.
$12
Top 3 companies account for 42.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIOM · AUSTEDO · Adempas · BEVESPI AEROSPHERE · BREO · BREZTRI · BYSTOLIC · CHANTIX · Cologuard Collection Kit · DUAKLIR PRESSAIR · DUPIXENT · Dexcom G6 Transmitter · Dymista · ELIQUIS · FARXIGA · FASENRA · INSPIRE · INTELLIS · JANUVIA · JARDIANCE · LINZESS · LOKELMA · LONHALA MAGNAIR · Livalo · NUCALA · Neupro · OPSUMIT · Otezla · Ozempic · PANCREAZE · PREVNAR 20 · Perforomist · RAYOS · REXULTI · Repatha · Rybelsus · SEGLENTIS · SMARTVEST · SPIRIVA · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · TEZSPIRE · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · Tymlos · UBRELVY · UTIBRON NEOHALER · Uloric · VALTOCO · VRAYLAR · Vascepa · Victoza · Wakix · Wegovy · XARELTO · XIFAXAN · Xhance · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
490
Per 100K population
94.5
County median income
$87,137
Nearest hospital
CHILTON MEDICAL CENTER
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rappaport is a clinical cardiology specialist, with above-average Medicare volume (top 2% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rappaport experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Rappaport performed 2,090 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rappaport receive payments from pharmaceutical companies?
Yes. Dr. Rappaport received a total of $3,066 from 43 companies across 220 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rappaport's costs compare to other pulmonary diseases in Wayne?
Dr. Rappaport's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rappaport) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Wayne
Browse pulmonary diseases in Wayne ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology